Salivary LL-37 secretion in individuals with Down syndrome is normal

被引:24
作者
Bachrach, G. [1 ]
Chaushu, G.
Zigmond, M.
Yefenof, E.
Stabholz, A.
Shapira, J.
Merrick, J.
Chaushu, S.
机构
[1] Hebrew Univ Jerusalem, Hadassah Sch Dent Med, Inst Dent Sci, IL-91120 Jerusalem, Israel
[2] Hebrew Univ Jerusalem, Hadassah Sch Dent Med, Lautenberg Ctr Gen & Tumor Immunol, IL-91120 Jerusalem, Israel
[3] Hebrew Univ Jerusalem, Hadassah Sch Dent Med, Dept Periodont, IL-91120 Jerusalem, Israel
[4] Hebrew Univ Jerusalem, Hadassah Sch Dent Med, Dept Pediat Dent, IL-91120 Jerusalem, Israel
[5] Hebrew Univ Jerusalem, Hadassah Sch Dent Med, Dept Orthodont, IL-91120 Jerusalem, Israel
[6] Chaim Sheba Med Ctr, Dept Cell & Maxillofacial Surg, IL-52621 Tel Hashomer, Israel
关键词
Down syndrome; saliva; LL-37; hCAP18; innate immunity; antimicrobial peptides;
D O I
10.1177/154405910608501012
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Antimicrobial peptides play an important role in the innate immune response. Deficiency in salivary LL-37 antimicrobial peptide has been implicated in periodontitis in patients with morbus Kostman syndrome. Down syndrome is associated with periodontitis, diminished salivary flow, and salivary immunoglobulin deficiency. In the present study, levels of LL-37 and its hCAP18 precursor were measured in saliva samples from young individuals with Down syndrome and compared with levels in those from age-matched healthy controls. LL-37 and human cathelicidin antimicrobial protein (hCAP18) were detected in whole but not in parotid saliva. hCAP18 was more abundant than LL-37. The concentrations of salivary hCAP18 and LL-37 were found to be higher in individuals with Down syndrome than in healthy controls, but their secretion rates were similar. We concluded that, while the adaptive immunity of individuals with Down syndrome is impaired at the oral mucosa, the secretion rate of the LL-37 component of the innate immune system is normal.
引用
收藏
页码:933 / 936
页数:4
相关论文
共 27 条
[11]   Down syndrome - A review of the literature [J].
Desai, SS .
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS, 1997, 84 (03) :279-285
[12]   Biochemical and antibacterial analysis of human wound and blister fluid [J].
Frohm, M ;
Gunne, H ;
Bergman, AC ;
Agerberth, B ;
Bergman, T ;
Boman, A ;
Liden, S ;
Jornvall, H ;
Boman, HG .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1996, 237 (01) :86-92
[13]   Cathelicidin antimicrobial peptides are expressed in salivary glands and saliva [J].
Murakami, M ;
Ohtake, T ;
Dorschner, RA ;
Gallo, RL .
JOURNAL OF DENTAL RESEARCH, 2002, 81 (12) :845-850
[14]   Endogenous antimicrobial peptides and skin infections in atopic dermatitis [J].
Ong, PY ;
Ohtake, T ;
Brandt, C ;
Strickland, I ;
Boguniewicz, M ;
Ganz, T ;
Gallo, RL ;
Leung, DYM .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (15) :1151-1160
[15]   PERIODONTAL-DISEASE AMONG CHILDREN WITH DOWNS-SYNDROME AND THEIR SIBLINGS [J].
ORNER, G .
JOURNAL OF DENTAL RESEARCH, 1976, 55 (05) :778-782
[16]   Susceptibilities of periodontopathogenic and cariogenic bacteria to antibacterial peptides, β-defensins and LL37, produced by human epithelial cells [J].
Ouhara, K ;
Komatsuzawa, H ;
Yamada, S ;
Shiba, H ;
Fujiwara, T ;
Ohara, M ;
Sayama, K ;
Hashimoto, K ;
Kurihara, H ;
Sugai, M .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 55 (06) :888-896
[17]   Deficiency of antibacterial peptides in patients with morbus Kostmann:: an observation study [J].
Pütsep, K ;
Carlsson, G ;
Boman, HG ;
Andersson, M .
LANCET, 2002, 360 (9340) :1144-1149
[18]   PERIODONTAL-DISEASE IN DOWNS-SYNDROME - A REVIEW [J].
REULANDBOSMA, W ;
VANDIJK, J .
JOURNAL OF CLINICAL PERIODONTOLOGY, 1986, 13 (01) :64-73
[19]   Streptococcus mutans fructosyltransferase interactions with glucans [J].
Rozen, R ;
Steinberg, D ;
Bachrach, G .
FEMS MICROBIOLOGY LETTERS, 2004, 232 (01) :39-43
[20]   PERIODONTAL-DISEASE ASSOCIATED WITH DOWNS-SYNDROME - ORTHOPANTOMOGRAPHIC EVALUATION [J].
SAXEN, L ;
AULA, S ;
WESTERMARCK, T .
JOURNAL OF PERIODONTOLOGY, 1977, 48 (06) :337-340